Selective targeting of the TLR4 co-receptor, MD2, prevents colon cancer growth and lung metastasis
Frontiers | Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inflammatory Pathways
Scavenger Receptor SREC-I Mediated Entry of TLR4 into Lipid Microdomains and Triggered Inflammatory Cytokine Release in RAW 264.7 Cells upon LPS Activation | PLOS ONE
Frontiers | Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview
CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4: Cell
Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. - Abstract - Europe PMC
Figure 1 | Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling | SpringerLink
Schematic diagram of TLR4 signaling pathways. MyD88 and TRIF-mediated... | Download Scientific Diagram
TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling | SpringerLink
Erlotinib protects against LPS-induced Endotoxicity because TLR4 needs EGFR to signal | PNAS
Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2 | Journal of Pharmacology and Experimental Therapeutics
LPS/TLR4 Signal Transduction Pathway-CUSABIO
A smooth operator for LPS responses | Nature Immunology
Vaccines | Free Full-Text | TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis